We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+15.56%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$883B
AUM Growth
+$71.1B
Cap. Flow
-$18.2B
Cap. Flow %
-2.06%
Top 10 Hldgs %
35.83%
Holding
3,193
New
153
Increased
2,010
Reduced
803
Closed
136

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.94B
2
AVGO icon
Broadcom
AVGO
+$2.74B
3
MSFT icon
Microsoft
MSFT
+$2.33B
4
AMD icon
Advanced Micro Devices
AMD
+$1.47B
5
GE icon
GE Aerospace
GE
+$1.27B

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.42B
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.44B
3
AAPL icon
Apple
AAPL
+$2.42B
4
FISV
Fiserv Inc
FISV
+$2.3B
5
LLY icon
Eli Lilly
LLY
+$1.78B

Sector Composition

Rank Sector Weight
1 Technology 34.73%
2 Financials 12.11%
3 Healthcare 10.97%
4 Consumer Discretionary 10.95%
5 Communication Services 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMRA icon
3101
Neumora Therapeutics
NMRA
$317M
-32,548
Closed -$33K
NOTE
3102
DELISTED
FiscalNote
NOTE
-2,537
Closed -$25K
NOVA
3103
DELISTED
Sunnova Energy
NOVA
-175,494
Closed -$66K
OCGN icon
3104
Ocugen
OCGN
$475M
-123,718
Closed -$88K
ONL
3105
Orion Office REIT
ONL
$161M
-23,650
Closed -$51K
OPAD icon
3106
Offerpad Solutions
OPAD
$22.5M
-1,093
Closed -$19K
OVID icon
3107
Ovid Therapeutics
OVID
$489M
-17,396
Closed -$6K
PHG icon
3108
Philips
PHG
$26.2B
-138,804
Closed -$3.26M
PLCE icon
3109
Children's Place
PLCE
$55.1M
-10,200
Closed -$90K
PMVP icon
3110
PMV Pharmaceuticals
PMVP
$67.2M
-33,600
Closed -$37K
PROK icon
3111
ProKidney
PROK
$304M
-43,108
Closed -$38K
PYXS icon
3112
Pyxis Oncology
PYXS
$201M
-22,220
Closed -$23K
QIPT
3113
DELISTED
Quipt Home Medical
QIPT
-16,802
Closed -$40K
RDZN icon
3114
Roadzen
RDZN
$113M
-14,460
Closed -$16K
REKR icon
3115
Rekor Systems
REKR
$94M
-34,757
Closed -$31K
LNAI
3116
Lunai Bioworks
LNAI
$10.7M
-565
Closed -$25K
RGLS
3117
DELISTED
Regulus Therapeutics
RGLS
-29,597
Closed -$52K
SCWO icon
3118
374Water
SCWO
$40.6M
-2,263
Closed -$8K
SERA icon
3119
Sera Prognostics
SERA
$79.1M
-11,333
Closed -$42K
SGMT icon
3120
Sagimet Biosciences
SGMT
$584M
-12,918
Closed -$43K
SLRN
3121
DELISTED
ACELYRIN
SLRN
-34,515
Closed -$86K
SMRT icon
3122
SmartRent
SMRT
$278M
-76,671
Closed -$93K
SONY icon
3123
Sony
SONY
$138B
-237,200
Closed -$6.02M
SST icon
3124
System1
SST
$19.8M
-1,760
Closed -$7K
STRO icon
3125
Sutro Biopharma
STRO
$353M
-3,689
Closed -$25K

Similar funds

T. Rowe Price Associates's Q2 2025 Portfolio in Review

As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
  • T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
  • T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
  • T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
  • T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
  • T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
  • T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.